These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22699458)

  • 21. LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease.
    Lee H; James WS; Cowley SA
    Biochem Soc Trans; 2017 Feb; 45(1):131-139. PubMed ID: 28202666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson's Disease.
    Kustrimovic N; Marino F; Cosentino M
    Curr Med Chem; 2019; 26(20):3719-3753. PubMed ID: 30306855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microglia and Parkinson's disease: footprints to pathology.
    Lazdon E; Stolero N; Frenkel D
    J Neural Transm (Vienna); 2020 Feb; 127(2):149-158. PubMed ID: 32016606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An inflammatory review of Parkinson's disease.
    Orr CF; Rowe DB; Halliday GM
    Prog Neurobiol; 2002 Dec; 68(5):325-40. PubMed ID: 12531233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current opinions and perspectives on the role of immune system in the pathogenesis of Parkinson's disease.
    Panaro MA; Cianciulli A
    Curr Pharm Des; 2012; 18(2):200-8. PubMed ID: 22229581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease.
    Maguire-Zeiss KA; Federoff HJ
    J Neural Transm (Vienna); 2010 Aug; 117(8):1019-25. PubMed ID: 20549523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innate immunity as the trigger of systemic autoimmune diseases.
    Saferding V; Blüml S
    J Autoimmun; 2020 Jun; 110():102382. PubMed ID: 31883831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets.
    Reynolds AD; Stone DK; Mosley RL; Gendelman HE
    J Immunol; 2009 Apr; 182(7):4137-49. PubMed ID: 19299711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of innate immunity and inflammation in Parkinson´s disease.
    Öberg M; Fabrik I; Fabrikova D; Zehetner N; Härtlova A
    Scand J Immunol; 2021 May; 93(5):e13022. PubMed ID: 33471378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease.
    Gelders G; Baekelandt V; Van der Perren A
    J Immunol Res; 2018; 2018():4784268. PubMed ID: 29850629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Innate inflammation in Parkinson's disease.
    Perry VH
    Cold Spring Harb Perspect Med; 2012 Sep; 2(9):a009373. PubMed ID: 22951445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cells in central nervous system autoimmunity.
    Sie C; Korn T
    Semin Immunopathol; 2017 Feb; 39(2):99-111. PubMed ID: 27888330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory impairment in untreated Parkinson's disease is not restricted to Tregs: other regulatory populations are also involved.
    Álvarez-Luquín DD; Arce-Sillas A; Leyva-Hernández J; Sevilla-Reyes E; Boll MC; Montes-Moratilla E; Vivas-Almazán V; Pérez-Correa C; Rodríguez-Ortiz U; Espinoza-Cárdenas R; Fragoso G; Sciutto E; Adalid-Peralta L
    J Neuroinflammation; 2019 Nov; 16(1):212. PubMed ID: 31711508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerogenic dendritic cells for autoimmune disease and transplantation.
    Thomson AW; Robbins PD
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii90-6. PubMed ID: 19022823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NADPH oxidase-derived H
    Hou L; Zhou X; Zhang C; Wang K; Liu X; Che Y; Sun F; Li H; Wang Q; Zhang D; Hong JS
    Redox Biol; 2017 Aug; 12():162-170. PubMed ID: 28237879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease.
    Gorelenkova Miller O; Behring JB; Siedlak SL; Jiang S; Matsui R; Bachschmid MM; Zhu X; Mieyal JJ
    Antioxid Redox Signal; 2016 Dec; 25(18):967-982. PubMed ID: 27224303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory Mechanisms in Parkinson's Disease: From Pathogenesis to Targeted Therapies.
    Lee SYH; Yates NJ; Tye SJ
    Neuroscientist; 2022 Oct; 28(5):485-506. PubMed ID: 33586516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammation and adaptive immunity in Parkinson's disease.
    Mosley RL; Hutter-Saunders JA; Stone DK; Gendelman HE
    Cold Spring Harb Perspect Med; 2012 Jan; 2(1):a009381. PubMed ID: 22315722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease.
    Kim YS; Joh TH
    Exp Mol Med; 2006 Aug; 38(4):333-47. PubMed ID: 16953112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parkinson disease and the immune system - associations, mechanisms and therapeutics.
    Tan EK; Chao YX; West A; Chan LL; Poewe W; Jankovic J
    Nat Rev Neurol; 2020 Jun; 16(6):303-318. PubMed ID: 32332985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.